Tianjin Medical University Cancer Institute & Hospital
Tianjin Medical University Cancer Institute & Hospital
Tianjing, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients | PDAC - Pancreatic Ductal Adenocarcinoma | Enrolling by invitation | Phase 2 | 2026-07-13 | NCT05947825 |